{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T18:04:56Z","timestamp":1792087496230,"version":"4.4.0"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2023,2,27]],"date-time":"2023-02-27T00:00:00Z","timestamp":1677456000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,2,27]],"date-time":"2023-02-27T00:00:00Z","timestamp":1677456000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["1R15HL135700-01A1"],"award-info":[{"award-number":["1R15HL135700-01A1"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drugs Aging"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1007\/s40266-023-01008-6","type":"journal-article","created":{"date-parts":[[2023,2,27]],"date-time":"2023-02-27T09:02:38Z","timestamp":1677488558000},"page":"377-390","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["A Motivational Interviewing Intervention to Improve Adherence to ACEIs\/ARBs among Nonadherent Older Adults with Comorbid Hypertension and Diabetes"],"prefix":"10.1007","volume":"40","author":[{"given":"Anjana","family":"Mohan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zahra","family":"Majd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael L.","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ekere J.","family":"Essien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jamie","family":"Barner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omar","family":"Serna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esteban","family":"Gallardo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc L.","family":"Fleming","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy","family":"Ordonez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcia M.","family":"Holstad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan M.","family":"Abughosh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,2,27]]},"reference":[{"key":"1008_CR1","unstructured":"Promotion NCfCDPaH. Heart Disease and Stroke. 2022 [cited; Available from: https:\/\/www.cdc.gov\/chronicdisease\/resources\/publications\/factsheets\/heart-disease-stroke.htm#:~:text=Leading%20risk%20factors%20for%20heart,unhealthy%20diet%2C%20and%20physical%20inactivity. Accessed July 2022."},{"key":"1008_CR2","unstructured":"(CDC) CfDCaP. Hypertension Cascade: Hypertension Prevalence, Treatment and Control Estimates Among US Adults Aged 18 Years and Older Applying the Criteria From the American College of Cardiology and American Heart Association\u2019s 2017 Hypertension Guideline\u2014NHANES 2015\u20132018. 2021."},{"issue":"10","key":"1008_CR3","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1016\/S0828-282X(06)70304-X","volume":"22","author":"DL McLean","year":"2006","unstructured":"McLean DL, Simpson SH, McAlister FA, Tsuyuki RT. Treatment and blood pressure control in 47,964 people with diabetes and hypertension: a systematic review of observational studies. Can J Cardiol. 2006;22(10):855\u201360.","journal-title":"Can J Cardiol"},{"issue":"6","key":"1008_CR4","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1001\/jama.2014.18574","volume":"313","author":"CA Emdin","year":"2015","unstructured":"Emdin CA, Rahimi K, Neal B, Callender T, Perkovic V, Patel A. Blood pressure lowering in type 2 diabetes: a systematic review and meta-analysis. JAMA. 2015;313(6):603\u201315.","journal-title":"JAMA"},{"issue":"2","key":"1008_CR5","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.ccl.2004.06.006","volume":"23","author":"PC Deedwania","year":"2005","unstructured":"Deedwania PC. Diabetes and hypertension, the deadly duet: importance, therapeutic strategy, and selection of drug therapy. Cardiol Clin. 2005;23(2):139\u201352.","journal-title":"Cardiol Clin"},{"issue":"1","key":"1008_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1758-5996-6-31","volume":"6","author":"P Lopez-Jaramillo","year":"2014","unstructured":"Lopez-Jaramillo P, Lopez-Lopez J, Lopez-Lopez C, Rodriguez-Alvarez MI. The goal of blood pressure in the hypertensive patient with diabetes is defined: now the challenge is go from recommendations to practice. Diabetol Metab Syndr. 2014;6(1):1\u201310.","journal-title":"Diabetol Metab Syndr"},{"issue":"9200","key":"1008_CR7","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/S0140-6736(99)12323-7","volume":"355","author":"Investigators HOPES","year":"2000","unstructured":"Investigators HOPES. Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. The Lancet. 2000;355(9200):253\u20139.","journal-title":"The Lancet"},{"issue":"3","key":"1008_CR8","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1056\/NEJM200001203420301","volume":"342","author":"S Yusuf","year":"2000","unstructured":"Yusuf S, Sleight P, Pogue Jf, Bosch J, Davies R, Dagenais G. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. N Engl J Med. 2000;342(3):145\u201353.","journal-title":"N Engl J Med"},{"issue":"8","key":"1008_CR9","first-page":"649","volume":"12","author":"CE Cooke","year":"2006","unstructured":"Cooke CE, Fatodu H. Physician conformity and patient adherence to ACE inhibitors and ARBs in patients with diabetes, with and without renal disease and hypertension, in a medicaid managed care organization. J Manag Care Pharm. 2006;12(8):649\u201355.","journal-title":"J Manag Care Pharm"},{"issue":"7258","key":"1008_CR10","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1136\/bmj.321.7258.412","volume":"321","author":"AI Adler","year":"2000","unstructured":"Adler AI, Stratton IM, Neil HAW, Yudkin JS, Matthews DR, Cull CA, et al. Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): prospective observational study. BMJ. 2000;321(7258):412\u20139.","journal-title":"BMJ"},{"issue":"10","key":"1008_CR11","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1056\/NEJM199803053381003","volume":"338","author":"RO Estacio","year":"1998","unstructured":"Estacio RO, Jeffers BW, Hiatt WR, Biggerstaff SL, Gifford N, Schrier RW. The effect of nisoldipine as compared with enalapril on cardiovascular outcomes in patients with non-insulin-dependent diabetes and hypertension. N Engl J Med. 1998;338(10):645\u201352.","journal-title":"N Engl J Med"},{"issue":"15","key":"1008_CR12","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1056\/NEJMoa0801317","volume":"358","author":"O Investigators","year":"2008","unstructured":"Investigators O. Telmisartan, ramipril, or both in patients at high risk for vascular events. N Engl J Med. 2008;358(15):1547\u201359.","journal-title":"N Engl J Med"},{"key":"1008_CR13","volume-title":"Adherence to long-term therapies: evidence for action","author":"E Sabat\u00e9","year":"2003","unstructured":"Sabat\u00e9 E, Sabat\u00e9 E. Adherence to long-term therapies: evidence for action. World Health Organization; 2003."},{"issue":"1","key":"1008_CR14","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1093\/tbm\/ibz133","volume":"11","author":"IM Kronish","year":"2021","unstructured":"Kronish IM, Thorpe CT, Voils CI. Measuring the multiple domains of medication nonadherence: findings from a Delphi survey of adherence experts. Transl Behav Med. 2021;11(1):104\u201313.","journal-title":"Transl Behav Med"},{"issue":"5","key":"1008_CR15","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1111\/j.1365-2125.2012.04167.x","volume":"73","author":"B Vrijens","year":"2012","unstructured":"Vrijens B, De Geest S, Hughes DA, Przemyslaw K, Demonceau J, Ruppar T, et al. A new taxonomy for describing and defining adherence to medications. Br J Clin Pharmacol. 2012;73(5):691\u2013705.","journal-title":"Br J Clin Pharmacol"},{"issue":"1","key":"1008_CR16","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1161\/STROKEAHA.108.522193","volume":"40","author":"F-Z Kettani","year":"2009","unstructured":"Kettani F-Z, Dragomir A, C\u00f4t\u00e9 R, Roy L, B\u00e9rard A, Blais L, et al. Impact of a better adherence to antihypertensive agents on cerebrovascular disease for primary prevention. Stroke. 2009;40(1):213\u201320.","journal-title":"Stroke"},{"key":"1008_CR17","doi-asserted-by":"publisher","first-page":"47","DOI":"10.2147\/CEOR.S15619","volume":"3","author":"L Degli Esposti","year":"2011","unstructured":"Degli Esposti L, Saragoni S, Benemei S, Batacchi P, Geppetti P, Di Bari M, et al. Adherence to antihypertensive medications and health outcomes among newly treated hypertensive patients. ClinicoEconomics Outcomes Res CEOR. 2011;3:47\u201354.","journal-title":"ClinicoEconomics Outcomes Res CEOR."},{"key":"1008_CR18","doi-asserted-by":"publisher","unstructured":"Nieuwlaat R, Wilczynski N, Navarro T, Hobson N, Jeffery R, Keepanasseril A, et al. Interventions for enhancing medication adherence. Cochrane Database Syst Rev. 2014;2014(11):CD000011. https:\/\/doi.org\/10.1002\/14651858.CD000011.pub4.","DOI":"10.1002\/14651858.CD000011.pub4"},{"issue":"9","key":"1008_CR19","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1111\/j.1467-789X.2011.00892.x","volume":"12","author":"M Armstrong","year":"2011","unstructured":"Armstrong M, Mottershead T, Ronksley P, Sigal R, Campbell T, Hemmelgarn B. Motivational interviewing to improve weight loss in overweight and\/or obese patients: a systematic review and meta-analysis of randomized controlled trials. Obes Rev. 2011;12(9):709\u201323.","journal-title":"Obes Rev"},{"key":"1008_CR20","volume-title":"Motivational interviewing: Helping people change","author":"WR Miller","year":"2012","unstructured":"Miller WR, Rollnick S. Motivational interviewing: Helping people change. Guilford Press; 2012."},{"issue":"2","key":"1008_CR21","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1037\/a0036322","volume":"59","author":"AP Turner","year":"2014","unstructured":"Turner AP, Sloan AP, Kivlahan DR, Haselkorn JK. Telephone counseling and home telehealth monitoring to improve medication adherence: results of a pilot trial among individuals with multiple sclerosis. Rehabil Psychol. 2014;59(2):136.","journal-title":"Rehabil Psychol"},{"key":"1008_CR22","doi-asserted-by":"publisher","first-page":"3186","DOI":"10.1016\/j.pec.2022.06.013","volume":"105","author":"M Papus","year":"2022","unstructured":"Papus M, Dima AL, Viprey M, Schott A-M, Schneider MP, Novais T. Motivational interviewing to support medication adherence in adults with chronic conditions: systematic review of randomized controlled trials. Patient Educ Couns. 2022;105:3186\u2013203.","journal-title":"Patient Educ Couns"},{"key":"1008_CR23","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1097\/MLR.0b013e3182984c1f","volume":"51","author":"JM Franklin","year":"2013","unstructured":"Franklin JM, Shrank WH, Pakes J, Sanf\u00e9lix-Gimeno G, Matlin OS, Brennan TA, et al. Group-based trajectory models: a new approach to classifying and predicting long-term medication adherence. Med care. 2013;51:789\u201396.","journal-title":"Med care"},{"issue":"10","key":"1008_CR24","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1002\/pds.3787","volume":"24","author":"JM Franklin","year":"2015","unstructured":"Franklin JM, Krumme AA, Tong AY, Shrank WH, Matlin OS, Brennan TA, et al. Association between trajectories of statin adherence and subsequent cardiovascular events. Pharmacoepidemiol Drug Saf. 2015;24(10):1105\u201313.","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"4","key":"1008_CR25","first-page":"202","volume":"12","author":"A Vadhariya","year":"2019","unstructured":"Vadhariya A, Fleming ML, Johnson ML, Essien EJ, Serna O, Esse T, et al. Group-based trajectory models to identify sociodemographic and clinical predictors of adherence patterns to statin therapy among older adults. Ame Health Drug Benefits. 2019;12(4):202.","journal-title":"Ame Health Drug Benefits."},{"issue":"1","key":"1008_CR26","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1146\/annurev.clinpsy.121208.131413","volume":"6","author":"DS Nagin","year":"2010","unstructured":"Nagin DS, Odgers CL. Group-based trajectory modeling in clinical research. Annu Rev Clin Psychol. 2010;6(1):109\u201338.","journal-title":"Annu Rev Clin Psychol"},{"issue":"9","key":"1008_CR27","first-page":"e537","volume":"21","author":"JM Franklin","year":"2015","unstructured":"Franklin JM, Krumme AA, Shrank WH, Matlin OS, Brennan TA, Choudhry NK. Predicting adherence trajectory using initial patterns of medication filling. Am J Manag Care. 2015;21(9):e537\u201344.","journal-title":"Am J Manag Care"},{"issue":"9","key":"1008_CR28","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1007\/s11606-016-3747-6","volume":"31","author":"W-H Lo-Ciganic","year":"2016","unstructured":"Lo-Ciganic W-H, Donohue JM, Jones BL, Perera S, Thorpe JM, Thorpe CT, et al. Trajectories of diabetes medication adherence and hospitalization risk: a retrospective cohort study in a large state Medicaid program. J Gen Intern Med. 2016;31(9):1052\u201360.","journal-title":"J Gen Intern Med"},{"issue":"10","key":"1008_CR29","first-page":"1053","volume":"25","author":"SM Abughosh","year":"2019","unstructured":"Abughosh SM, Vadhariya A, Johnson ML, Essien EJ, Esse TW, Serna O, et al. Enhancing statin adherence using a motivational interviewing intervention and past adherence trajectories in patients with suboptimal adherence. J Manag Care Spec Pharm. 2019;25(10):1053\u201362.","journal-title":"J Manag Care Spec Pharm"},{"key":"1008_CR30","doi-asserted-by":"publisher","first-page":"1935","DOI":"10.2147\/PPA.S270809","volume":"14","author":"R Paranjpe","year":"2020","unstructured":"Paranjpe R, Johnson ML, Essien EJ, Barner JC, Serna O, Gallardo E, et al. Group-based trajectory modeling to identify patterns of adherence and its predictors among older adults on Angiotensin-Converting Enzyme Inhibitors (ACEIs)\/Angiotensin Receptor Blockers (ARBs). Patient Prefer Adherence. 2020;14:1935\u201347.","journal-title":"Patient Prefer Adherence"},{"issue":"1","key":"1008_CR31","first-page":"63","volume":"22","author":"SM Abughosh","year":"2016","unstructured":"Abughosh SM, Wang X, Serna O, Henges C, Masilamani S, Essien EJ, et al. A Pharmacist telephone intervention to identify adherence barriers and improve adherence among nonadherent patients with comorbid hypertension and diabetes in a medicare advantage plan. J Manag Care Spec Pharm. 2016;22(1):63\u201373.","journal-title":"J Manag Care Spec Pharm"},{"issue":"5","key":"1008_CR32","first-page":"549","volume":"23","author":"S Abughosh","year":"2017","unstructured":"Abughosh S, Wang X, Serna O, Esse T, Mann A, Masilamani S, et al. A motivational interviewing intervention by pharmacy students to improve medication adherence. J Manag Care Spec Pharm. 2017;23(5):549\u201360.","journal-title":"J Manag Care Spec Pharm"},{"issue":"1","key":"1008_CR33","first-page":"63","volume":"22","author":"SM Abughosh","year":"2016","unstructured":"Abughosh SM, Wang X, Serna O, Henges C, Masilamani S, James Essien E, et al. A pharmacist telephone intervention to identify adherence barriers and improve adherence among nonadherent patients with comorbid hypertension and diabetes in a medicare advantage plan. J Manag Care Spec Pharm. 2016;22(1):63\u201373.","journal-title":"J Manag Care Spec Pharm"},{"issue":"4","key":"1008_CR34","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1093\/eurheartj\/ehi603","volume":"27","author":"MH van Der Wal","year":"2006","unstructured":"van Der Wal MH, Jaarsma T, Moser DK, Veeger NJ, van Gilst WH, van Veldhuisen DJ. Compliance in heart failure patients: the importance of knowledge and beliefs. Eur Heart J. 2006;27(4):434\u201340.","journal-title":"Eur Heart J"},{"issue":"2","key":"1008_CR35","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.ijcard.2007.10.011","volume":"125","author":"MH van der Wal","year":"2008","unstructured":"van der Wal MH, Jaarsma T. Adherence in heart failure in the elderly: problem and possible solutions. Int J Cardiol. 2008;125(2):203\u20138.","journal-title":"Int J Cardiol"},{"issue":"4","key":"1008_CR36","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1111\/j.0889-7204.2002.01643.x","volume":"17","author":"P Bohachick","year":"2002","unstructured":"Bohachick P, Burke LE, Sereika S, Murali S, Dunbar-Jacob J. Adherence to angiotensin-converting enzyme inhibitor therapy for heart failure. Prog Cardiovasc Nurs. 2002;17(4):160\u20136.","journal-title":"Prog Cardiovasc Nurs"},{"key":"1008_CR37","doi-asserted-by":"crossref","unstructured":"Koh-Knox CP. Motivational interviewing in health care: helping patients change behavior. Am J Pharm Educ. 2009;73(7):127.","DOI":"10.5688\/aj7307127"},{"issue":"2","key":"1008_CR38","first-page":"139","volume":"85","author":"DM Maurer","year":"2012","unstructured":"Maurer DM. Screening for depression. Am Fam Physician. 2012;85(2):139\u201344.","journal-title":"Am Fam Physician"},{"key":"1008_CR39","first-page":"25","volume-title":"Proportion of days covered (PDC) as a preferred method of measuring medication adherence","author":"DP Nau","year":"2012","unstructured":"Nau DP. Proportion of days covered (PDC) as a preferred method of measuring medication adherence, vol. 6. Springfield: Pharmacy Quality Alliance; 2012. p. 25."},{"key":"1008_CR40","unstructured":"Cubanski J, Damico A. Key facts about Medicare Part D enrollment, premiums, and cost sharing in 2021. Kaiser Family Foundation. 2021. https:\/\/www.kff.org\/medicare\/issue-brief\/key-facts-about-medicare-part-d-enrollment-premiums-and-cost-sharing-in-2021. Accessed July 2022."},{"issue":"35","key":"1008_CR41","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000027143","volume":"100","author":"PJ Campbell","year":"2021","unstructured":"Campbell PJ, Axon DR, Taylor AM, Smith K, Pickering M, Black H, et al. Hypertension, cholesterol and diabetes medication adherence, health care utilization and expenditure in a Medicare Supplemental sample. Medicine (Baltimore). 2021;100(35): e27143.","journal-title":"Medicine (Baltimore)"},{"issue":"7","key":"1008_CR42","doi-asserted-by":"publisher","first-page":"1756","DOI":"10.1016\/j.pec.2020.12.009","volume":"104","author":"A Mohan","year":"2021","unstructured":"Mohan A, Vadhariya A, Majd Z, Esse TW, Serna O, Abughosh SM. Impact of a motivational interviewing intervention targeting statins on adherence to concurrent hypertension or diabetes medications. Patient Educ Couns. 2021;104(7):1756\u201364.","journal-title":"Patient Educ Couns"},{"key":"1008_CR43","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.amepre.2022.02.019","volume":"63","author":"SLNP Jackson","year":"2022","unstructured":"Jackson SLNP, Chang A, Schieb L, et al. Antihypertensive and statin medication adherence among medicare beneficiaries. Am J Prev Med. 2022;63:313\u201323.","journal-title":"Am J Prev Med"},{"issue":"Suppl 1","key":"1008_CR44","doi-asserted-by":"publisher","first-page":"S11","DOI":"10.2337\/dc13-S011","volume":"36","author":"DA American","year":"2013","unstructured":"American DA. Standards of medical care in diabetes\u20132013. Diabetes Care. 2013;36(Suppl 1):S11-66.","journal-title":"Diabetes Care"},{"issue":"2","key":"1008_CR45","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1056\/NEJMoa053107","volume":"354","author":"FF Hou","year":"2006","unstructured":"Hou FF, Zhang X, Zhang GH, Xie D, Chen PY, Zhang WR, et al. Efficacy and safety of benazepril for advanced chronic renal insufficiency. N Engl J Med. 2006;354(2):131\u201340.","journal-title":"N Engl J Med"},{"issue":"2","key":"1008_CR46","first-page":"186","volume":"27","author":"Z Majd","year":"2021","unstructured":"Majd Z, Mohan A, Paranjpe R, Abughosh SM. Identifying adherent patients to newly initiated statins using previous adherence to chronic medications. J Manag Care Spec Pharm. 2021;27(2):186\u201397.","journal-title":"J Manag Care Spec Pharm"},{"issue":"3","key":"1008_CR47","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1331\/JAPhA.2014.13180","volume":"54","author":"JA Owen","year":"2014","unstructured":"Owen JA. Medicare star ratings: Stakeholder proceedings on community pharmacy and managed care partnerships in quality: American Pharmacists Association and Academy of Managed Care Pharmacy. J Am Pharm Assoc. 2014;54(3):228\u201340.","journal-title":"J Am Pharm Assoc"},{"issue":"3","key":"1008_CR48","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1097\/MLR.0000000000001067","volume":"57","author":"JT Lloyd","year":"2019","unstructured":"Lloyd JT, Maresh S, Powers CA, Shrank WH, Alley DE. How much does medication nonadherence cost the medicare fee-for-service program? Med Care. 2019;57(3):218\u201324.","journal-title":"Med Care"},{"issue":"10","key":"1008_CR49","first-page":"994","volume":"20","author":"MC Roebuck","year":"2014","unstructured":"Roebuck MC. Medical cost offsets from prescription drug utilization among Medicare beneficiaries. J Manag Care Spec Pharm. 2014;20(10):994\u20135.","journal-title":"J Manag Care Spec Pharm"},{"issue":"9","key":"1008_CR50","first-page":"556","volume":"18","author":"R Lopert","year":"2012","unstructured":"Lopert R, Shoemaker JS, Davidoff A, Shaffer T, Abdulhalim AM, Lloyd J, et al. Medication adherence and Medicare expenditure among beneficiaries with heart failure. Am J Manag Care. 2012;18(9):556\u201363.","journal-title":"Am J Manag Care"},{"issue":"6","key":"1008_CR51","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1016\/j.japh.2020.08.021","volume":"60","author":"L Wheat","year":"2020","unstructured":"Wheat L, Roane TE, Connelly A, Zeigler M, Wallace J, Kim JH, et al. Using a pharmacist-community health worker collaboration to address medication adherence barriers. J Am Pharm Assoc (2003). 2020;60(6):1009\u201314.","journal-title":"J Am Pharm Assoc (2003)"},{"issue":"4S","key":"1008_CR52","first-page":"S20","volume":"58","author":"C Stanton-Robinson","year":"2018","unstructured":"Stanton-Robinson C, Al-Jumaili AA, Jackson A, Catney C, Veach S, Witry MJ. Evaluation of community pharmacist-provided telephone interventions to improve adherence to hypertension and diabetes medications. J Am Pharm Assoc (2003). 2018;58(4S):S20\u20134.","journal-title":"J Am Pharm Assoc (2003)"},{"issue":"1","key":"1008_CR53","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1080\/13561820.2019.1633289","volume":"34","author":"S Ray","year":"2020","unstructured":"Ray S, Lokken J, Whyte C, Baumann A, Oldani M. The impact of a pharmacist-driven, collaborative practice on diabetes management in an Urban underserved population: a mixed method assessment. J Interprof Care. 2020;34(1):27\u201335.","journal-title":"J Interprof Care"},{"key":"1008_CR54","unstructured":"Heiser S. AAMC report reinforces mounting physician shortage. Association of American Medical Colleges. https:\/\/www. aamc. org\/news-insights\/press-releases\/aamc-reportreinforces-mounting-physician-shortage. 2021. Accessed July 2022."},{"issue":"3","key":"1008_CR55","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1080\/03601277.2013.802186","volume":"40","author":"EW Holt","year":"2014","unstructured":"Holt EW, Rung AL, Leon KA, Firestein C, Krousel-Wood MA. Medication adherence in older adults: a qualitative study. Educ Gerontol. 2014;40(3):198\u2013211.","journal-title":"Educ Gerontol"},{"issue":"9","key":"1008_CR56","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1016\/j.sapharm.2018.09.021","volume":"15","author":"B Presley","year":"2019","unstructured":"Presley B, Groot W, Pavlova M. Pharmacy-led interventions to improve medication adherence among adults with diabetes: A systematic review and meta-analysis. Res Social Adm Pharm. 2019;15(9):1057\u201367.","journal-title":"Res Social Adm Pharm"},{"key":"1008_CR57","unstructured":"Albrecht S. The pharmacist\u2019s role in medication adherence. US Pharm. 2011;36(5):45\u20138."},{"issue":"3","key":"1008_CR58","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1007\/s12160-011-9291-z","volume":"42","author":"U Menon","year":"2011","unstructured":"Menon U, Belue R, Wahab S, Rugen K, Kinney AY, Maramaldi P, et al. A randomized trial comparing the effect of two phone-based interventions on colorectal cancer screening adherence. Ann Behav Med. 2011;42(3):294\u2013303.","journal-title":"Ann Behav Med"},{"issue":"9","key":"1008_CR59","doi-asserted-by":"publisher","first-page":"1881","DOI":"10.1097\/HJH.0000000000001382","volume":"35","author":"AI Kurdi","year":"2017","unstructured":"Kurdi AI, Chen LC, Elliott RA. Exploring factors associated with patients\u2019 adherence to antihypertensive drugs among people with primary hypertension in the United Kingdom. J Hypertens. 2017;35(9):1881\u201390.","journal-title":"J Hypertens"},{"key":"1008_CR60","doi-asserted-by":"crossref","unstructured":"Michel B, Brent ME. Adherence in hypertension. Circ Res. 2019;124(7):1124\u201340.","DOI":"10.1161\/CIRCRESAHA.118.313220"},{"issue":"11","key":"1008_CR61","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1038\/hr.2013.85","volume":"36","author":"S Shin","year":"2013","unstructured":"Shin S, Song H, Oh SK, Choi KE, Kim H, Jang S. Effect of antihypertensive medication adherence on hospitalization for cardiovascular disease and mortality in hypertensive patients. Hypertens Res. 2013;36(11):1000\u20135.","journal-title":"Hypertens Res"},{"issue":"6","key":"1008_CR62","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1016\/j.sapharm.2012.12.002","volume":"9","author":"ZA Marcum","year":"2013","unstructured":"Marcum ZA, Zheng Y, Perera S, Strotmeyer E, Newman AB, Simonsick EM, et al. Prevalence and correlates of self-reported medication non-adherence among older adults with coronary heart disease, diabetes mellitus, and\/or hypertension. Res Social Adm Pharm. 2013;9(6):817\u201327.","journal-title":"Res Social Adm Pharm"},{"issue":"4","key":"1008_CR63","doi-asserted-by":"publisher","DOI":"10.5812\/numonthly.29863","volume":"7","author":"Z Saadat","year":"2015","unstructured":"Saadat Z, Nikdoust F, Aerab-Sheibani H, Bahremand M, Shobeiri E, Saadat H, et al. Adherence to antihypertensives in patients with comorbid condition. Nephrourol Mon. 2015;7(4): e29863.","journal-title":"Nephrourol Mon."}],"container-title":["Drugs & Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40266-023-01008-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40266-023-01008-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40266-023-01008-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,15]],"date-time":"2025-04-15T11:12:48Z","timestamp":1744715568000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40266-023-01008-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,27]]},"references-count":63,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,4]]}},"alternative-id":["1008"],"URL":"https:\/\/doi.org\/10.1007\/s40266-023-01008-6","relation":{},"ISSN":["1170-229X","1179-1969"],"issn-type":[{"value":"1170-229X","type":"print"},{"value":"1179-1969","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,27]]},"assertion":[{"value":"25 January 2023","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 February 2023","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was funded by the National Heart, Lung, and Blood Institute (NHLBI), 1R15HL135700-01A1.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"SA reports grants from CARsgen and Valeant Pharmaceuticals, outside the submitted work. JB reports personal fees from University of Houston during the conduct of the study and a grant from Centers for Disease Control, Texas Health and Human Services, and Pharmaceutical Research Manufacturers of America Foundation, outside the submitted work. MF reports grants from National Heart, Lung, and Blood Institute and National Institute on Minority Health and Health Disparities (U-54). MF also reports contracts from Texas Health and Human Services Commission and CoI funding on a grant from Texas Council for Developmental Disabilities, outside the submitted work. EG is an employee of CareAllies, a subsidiary of Cigna, outside of the submitted work. The other authors declare that they have no conflict of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"Not available.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Availability of Data and Material"}},{"value":"The study was approved by the institutional review board at the University of Houston and is compliant with the Declaration of Helsinki.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"Participants receiving the intervention consented verbally over the initial phone call to participation using a script in accordance with all NIH human subject ethical guidelines and the University of Houston IRB requirements for recruitment and informed consent.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"Not available.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code Availability"}},{"value":"Design\/conduct of the study (SA, MF, MH); acquisition of subjects and\/or data (SA, EG, NO, OS); analysis and interpretation of data (AM, ZM, SA, MJ, JB, EE, MH); preparation of manuscript (AM, ZM, SA). All authors contributed to the review and editing and approved the final manuscript.","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Authors\u2019 Contributions"}}]}}